Journal of Hepatology
At the dawn of potent therapeutics for fatty liver disease – introducing the miniseries on promising pharmacological targets for NASH
Posted on
OUr founders
ISO 9001 Certified
OUr Institutionnal Supporters
Our network
Foundation for innovation
in Cardiometabolism and Nutrition
